UNC to Test Injectable Long-Acting Implant to Prevent HIV

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention. Scientists in the UNC School of Medicine’s Division of Infectious Diseases and the UNC Eshelman School of Pharmacy are developing an… Read More

Dr. Kevin Robertson honored for his work to understand the neurological effects of HIV

Kevin Robertson, PhD, is a professor of neurology and the director of the AIDS Neurological Center. He has led global research initiatives, and trained clinicians and researchers all over the world to establish research centers in Uganda, South Africa, Malawi, Nigeria, India, Thailand, Peru, and Zimbabwe. This summer, Robertson was recognized for his role in training the next… Read More

Early HIV Treatment Can Prevent Transmission to Uninfected Partners

Antiretroviral therapy (ART) for HIV infection provides consistent protection against the sexual transmission of the HIV virus from infected men and women to their HIV-uninfected sexual partners. These findings were announced on Monday, July 20 by researcher Dr. Myron Cohen at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment & Prevention in Vancouver, Canada. Cohen,… Read More

International Conference on HIV Treatment and Prevention Adherence

IAPAC

The International Association of Providers of AIDS Care (IAPAC) is hosting the 10th annual International Conference on HIV Treatment and Prevention Adherence. June 28-30, 2015 Eden Roc Miami Beach Hotel, Miami, FL The conference provides an annual forum for the presentation and discussion of state-of-the-science HIV treatment and biomedical prevention adherence research, as well as… Read More